Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Public Patent Foundation, Inc. v. Glaxosmithkline Consumer Healthcare, L.P.
Case Number:
2:09-cv-05881
Court:
Nature of Suit:
Judge:
Firms
-
August 11, 2011
GSK Wins False Patent Marking Suit Over Citrucel
GlaxoSmithKline PLC on Wednesday prevailed in a suit alleging it falsely marked the laxative Citrucel with expired patents, with a New York federal judge ruling following a bench trial that there was no evidence the company knew the patents were expired or intended to deceive the public.
-
March 25, 2011
False Marking Law Found Constitutional In GSK Case
A New York federal judge ruled Tuesday that the false marking statute is constitutional, rejecting a bid by GlaxoSmithKline PLC to dismiss a suit that claims the company marked its laxative Citrucel with expired patents.